Skip to main content
Legal & Compliance

Our Commitment to
Transparency and Trust

Laborate Pharmaceuticals operates with full legal and regulatory transparency. Find all our policies, notices, and compliance documents in one place.

Privacy & Data Protection

How We Handle Your Personal Information

Laborate Pharmaceuticals aligns its data processing practices with the Digital Personal Data Protection Act 2023 (DPDPA), the Information Technology Act 2000, and GDPR principles. We operate on a minimal data collection model: we collect only what is necessary, for defined purposes, and retain it no longer than required.

  • Purpose limitation — We use data only for the purpose it was collected.
  • Data minimisation — We request only information we genuinely need.
  • Your rights — Access, correction, deletion, and objection rights clearly explained.
  • Secure handling — Industry-standard safeguards for all personal data.
Read Privacy Policy

Our Privacy at a Glance

  • DPDPA 2023 Aligned India's Digital Personal Data Protection Act 2023 governs how we handle all personal data submitted through this website.
  • No Third-Party Advertising Data We do not sell, rent, or trade personal data to advertising networks or data brokers.
  • Consent-Gated Analytics Google Analytics (GA4) only loads after you have explicitly accepted analytics cookies via the Cookie Preference Centre.
  • 30-Day Response Commitment All data rights requests are acknowledged within 72 hours and resolved within 30 calendar days.
Full Privacy Policy
Patient Safety

Reporting Adverse Drug Events

Laborate Pharmaceuticals maintains a formal Pharmacovigilance system under Schedule Y of the Drugs & Cosmetics Act 1940, ICH E6 guidelines, and CDSCO requirements. All adverse drug reactions — whether serious or non-serious — must be reported promptly.

If you have experienced or observed an adverse drug reaction to a Laborate product, please contact our Pharmacovigilance team directly. All reports are treated as priority cases and handled by qualified medical assessors.

Pharmacovigilance Team pv@laborate.com
Report an Adverse Event

Serious Adverse Events

Events resulting in hospitalisation, disability, life-threatening situations, or death must be reported to our PV team within 15 days of awareness. All ICSRs are submitted to PvPI (Pharmacovigilance Programme of India).

Non-Serious Reports Welcome

All adverse events, including minor unexpected reactions, are valuable to our safety database. We encourage healthcare professionals and patients to report any unexpected product response, regardless of severity.

Quality Complaints

Product quality complaints — including defective packaging, contamination, mislabelling, or batch anomalies — should also be reported to our PV team at pv@laborate.com for immediate investigation.

Accessibility

Accessible by Design

We target WCAG 2.2 Level AA conformance across all Laborate web properties. Accessibility is built into our development lifecycle — not added as an afterthought.

Our Accessibility Statement documents where we are, where we are not yet, and our roadmap for improvement.

Read Accessibility Statement

WCAG 2.2 AA Target

All new pages designed against WCAG 2.2 Level AA success criteria: perceivable, operable, understandable, robust.

Full Keyboard Navigation

All interactive elements are reachable and operable via keyboard alone. Focus indicators are visible and meet contrast requirements.

Screen Reader Compatible

Tested with NVDA, JAWS, and VoiceOver. ARIA landmarks, roles, and live regions used throughout for clear structural navigation.

Report an Accessibility Barrier

If part of our website is difficult to use, tell us. We investigate every report, prioritise fixes by severity, and respond within 10 business days.

Have a Question About Our Legal Policies?

Our Legal & Compliance team is here to help with policy questions, data rights requests, and regulatory queries. We respond to all enquiries within 5 business days.

Contact Compliance Team